ClinicalTrials.gg
CompletedNCT05247242Updated Jan 20, 2025

Physical Activity and Social Engagement for Persons With Disabilities in an Underserved Community

An interventional study of Lakeshore Online Fitness (Online) and Get Active with Virtual Reality (VR) in Disability Physical, Chronic Conditions, Multiple and Aging, sponsored by University of Alabama at Birmingham. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-20.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Using a community-based participatory approach, this project aims to evaluate the feasibility, acceptability, and preliminary efficacy of two technology-driven group activity programs on socioemotional health and physical activity in a local underserved community, Tarrant, Alabama. Participants will complete two six-week programs, specifically Lakeshore Online Fitness (Online) and Get Active with Virtual Reality (VR).

Read the detailed description

This project will utilize a cross-over randomized design where participants will initially be randomized into either the Online or VR intervention group. After completing the initial six weeks of the assigned intervention, participants will cross over and complete six weeks of the other intervention. No washout period is included due to several reasons, including no known washout period for certain socioemotional outcomes have been established by prior literature, ethical concerns in requiring return to baseline levels during washout, and a prolonged washout period would negatively impact participant adherence and retention to the study. Psychosocial metrics will be collected at the end of each activity session through surveys.

02

Conditions studied

  • Disability Physical
  • Chronic Conditions, Multiple
  • Aging
03

In context

Multiple Chronic Conditions

89 studies on the registry are indexed under Multiple Chronic Conditions; 16 are open to participants now.

This study's enrollment of 10 is below the median of 128 across 71 interventional studies indexed under Multiple Chronic Conditions.

Browse Multiple Chronic Conditions studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,421 studies on the registry; 277 are open to participants now.

Of its 164 completed or terminated interventional studies of FDA-regulated products, 130 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Resident of Tarrant, Alabama
  • 18 years or older with a physical disability or chronic health condition or older than 60 years
  • Fluent in English

Exclusion criteria

Exclusion Criteria:

  • Visual impairment that interferes with television viewing
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    Tarrant Community Fitness Program: LOF-VR

    LOF-VR

    Behavioral: Lakeshore Online Fitness (Online) · Behavioral: Get Active with Virtual Reality (VR)

  • Experimental
    Tarrant Community Fitness Program: VR-LOF

    VR-LOF

    Behavioral: Lakeshore Online Fitness (Online) · Behavioral: Get Active with Virtual Reality (VR)

Interventions

  • BehavioralLakeshore Online Fitness (Online)

    Online physical activity program delivered to residents of Tarrant, AL via teleconferencing technology to a local community center. Instructors from Lakeshore will lead the physical activity program. This intervention will last six weeks.

  • BehavioralGet Active with Virtual Reality (VR)

    Participants will utilize the Oculus Quest 2 virtual reality headset, which is a head-mounted display system where users can interact with a virtual environment in a gaming setting. The Oculus Quest 2 incorporates social features where participants can interact with other users. This VR intervention will include periods of gameplay where participants can play games in either competitive or cooperative settings. This intervention will last six weeks.

06

What researchers measure

Primary outcomes

  1. Change in Social Isolation from Baseline to 12 weeks

    PROMIS Item Bank v2.0 - Social Isolation - SF 8a

    Time frame: 12 Weeks

Secondary outcomes

  1. Change in Self-efficacy from Baseline to 12 weeks

    Self-efficacy for Exercise (SEE) Scale

    Time frame: 12 Weeks

  2. Change in Loneliness from Baseline to 12 weeks

    NIH Toolbox Item Bank v2.0-Loneliness (Ages 18+)-Fixed Form

    Time frame: 12 Weeks

  3. Change in Positive Affect from Baseline to 12 weeks

    NIH Toolbox Item Bank v2.0-Positive Affect

    Time frame: 12 Weeks

  4. Change in Health-related quality of life from Baseline to 12 weeks

    SF-36v2

    Time frame: 12 Weeks

  5. Change in Physical activity from Baseline to 12 weeks

    Physical Activity Scale for Individuals with Physical Disabilities (PASIPD)

    Time frame: 12 Weeks

  6. Change in Enjoyment from Baseline to 12 weeks

    Visual Analog Scale (VAS) \& Modified Physical Activity Enjoyment Scale (PACES)

    Time frame: 12 Weeks

  7. Change in Physical Function from Baseline to 12 weeks

    Physical Function - Short Form 20a

    Time frame: 12 Weeks

07

Study locations

1 site
  • Tarrant Parks and Recreation
    Tarrant, Alabama 35217, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2022 to primary completion in Dec 2023, 17 months.

Of 59 non-industry interventional studies with no phase under Multiple Chronic Conditions, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 37. This study's 17 months is below that.

Counting every sponsor, half of 59 studies reached it within 20 months; a quarter within 11 and three quarters within 37.

Multiple Chronic Conditions covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 18, 2022
First posted
Feb 18, 2022
StartActual
Jul 19, 2022
Primary completionActual
Dec 27, 2023
CompletionActual
Dec 27, 2023
Last update
Jan 20, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05247242
Collaborators
Lakeshore Foundation
Responsible party
Laurie A Malone, PhD (Researcher IV, University of Alabama at Birmingham) — Principal investigator
First posted
Feb 18, 2022
Start date
Jul 19, 2022
Primary completion
Dec 27, 2023
Completion
Dec 27, 2023
Last update
Jan 20, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion